PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Aug 7, 2025, after the close
10-Q filed Aug 7, 2025, 38 days after period end · 0001558370-25-010796
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $178.88M | $186.70M | $213.81M | $165.53M |
| Net Income | -$64.85M | -$99.18M | -$198.88M | -$152.09M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$0.83 |
| -$1.29 |
| -$2.66 |
| -$2.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.